Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NR3C2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of NR3C2 mRNA | decreases expression | 20406850
|
C101850 |
3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide |
3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 16750840
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of NR3C2 protein | affects expression | 20106945
|
D000450 |
Aldosterone |
Aldosterone affects the localization of NR3C2 protein | affects localization | 17596522
|
D000450 |
Aldosterone |
Aldosterone binds to and results in increased activity of NR3C2 protein | affects binding|increases activity | 17105867
|
D000450 |
Aldosterone |
Aldosterone results in increased activity of NR3C2 protein | increases activity | 15780662
|
D000450 |
Aldosterone |
Dihydrotestosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | decreases reaction|increases activity | 17105867
|
D000450 |
Aldosterone |
Metribolone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | decreases reaction|increases activity | 17105867
|
D000450 |
Aldosterone |
Testosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | decreases reaction|increases activity | 17105867
|
D000450 |
Aldosterone |
Aldosterone promotes the reaction [NR3C2 protein binds to CREBBP protein] | affects binding|increases reaction | 19966502
|
D000450 |
Aldosterone |
Aldosterone results in increased activity of NR3C2 protein | increases activity | 15974890
|
D000450 |
Aldosterone |
Aldosterone results in increased expression of and results in increased localization of NR3C2 protein | increases expression|increases localization | 19966502
|
D000450 |
Aldosterone |
NR3C2 protein promotes the reaction [Aldosterone results in increased expression of GAS6 protein] | increases expression|increases reaction | 19564549
|
D000450 |
Aldosterone |
Aldosterone binds to and results in increased activity of NR3C2 protein | affects binding|increases activity | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to NCOA1 protein alternative form | affects binding | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to NCOA5 protein | affects binding | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to NCOA6 protein alternative form | affects binding | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to NRIP1 protein alternative form | affects binding | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to NSD1 protein | affects binding | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to PPARGC1A protein alternative form | affects binding | 15761029
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to TRIM24 protein | affects binding | 15761029
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone binds to NR3C2 protein | affects binding | 17105867
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | decreases reaction|increases activity | 17105867
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NR3C2 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NR3C2 mRNA | decreases expression | 20106945
|
D001761 |
Bleomycin |
Bleomycin results in decreased expression of NR3C2 mRNA | decreases expression | 15808516
|
D002220 |
Carbamazepine |
Carbamazepine results in increased expression of NR3C2 mRNA | increases expression | 17112801
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of NR3C2 mRNA | increases expression | 16644059
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in decreased expression of NR3C2 mRNA | affects cotreatment|decreases expression | 18636392
|
D003345 |
Corticosterone |
Corticosterone binds to NR3C2 protein | affects binding | 16061183
|
D003348 |
Cortisone |
Cortisone results in increased activity of NR3C2 protein | increases activity | 15780662
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NR3C2 mRNA | decreases expression | 20106945
|
D003350 |
Cortodoxone |
Cortodoxone results in increased activity of NR3C2 protein | increases activity | 15780662
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of NR3C2 mRNA | increases expression | 19022236
|
C035144 |
drospirenone |
drospirenone binds to NR3C2 protein | affects binding | 1493716 14667981
|
C414690 |
eplerenone |
eplerenone binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 15974890
|
C414690 |
eplerenone |
eplerenone binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 15761029
|
D000431 |
Ethanol |
Ethanol results in decreased expression of NR3C2 mRNA | decreases expression | 16925589
|
D000431 |
Ethanol |
Ethanol results in increased expression of NR3C2 mRNA | increases expression | 17920746
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of NR3C2 mRNA | increases expression | 18035473
|
D005473 |
Fluoxetine |
Fluoxetine results in decreased expression of NR3C2 mRNA | decreases expression | 11406320
|
D006854 |
Hydrocortisone |
Hydrocortisone results in increased activity of NR3C2 protein | increases activity | 15780662
|
D006854 |
Hydrocortisone |
Hydrocortisone binds to and affects the activity of NR3C2 protein | affects activity|affects binding | 15761029
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of NR3C2 mRNA | increases expression | 15469884
|
D008713 |
Methimazole |
Methimazole results in decreased expression of NR3C2 mRNA | decreases expression | 17403546
|
D015741 |
Metribolone |
Metribolone binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 17105867
|
D015741 |
Metribolone |
Metribolone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | decreases reaction|increases activity | 17105867
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in decreased expression of NR3C2 mRNA | affects cotreatment|decreases expression | 18636392
|
C494474 |
perchlorate |
perchlorate results in decreased expression of NR3C2 mRNA | decreases expression | 17403546
|
D010656 |
Phenylephrine |
Phenylephrine promotes the reaction [NR3C2 protein binds to CREBBP protein] | affects binding|increases reaction | 19966502
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of and results in increased localization of NR3C2 protein | increases expression|increases localization | 19966502
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of NR3C2 mRNA | increases expression | 16533503
|
D010656 |
Phenylephrine |
Spironolactone inhibits the reaction [Phenylephrine results in increased localization of NR3C2 protein] | decreases reaction|increases localization | 19966502
|
D011374 |
Progesterone |
Progesterone binds to NR3C2 protein | affects binding | 14667981
|
D011374 |
Progesterone |
Progesterone binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 15761029 14667981
|
D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of NR3C2 mRNA | decreases expression | 17403546
|
D012964 |
Sodium |
NR3C2 protein affects the abundance of Sodium | affects abundance | 16061183 15802372
|
C017947 |
sodium arsenite |
sodium arsenite affects the activity of NR3C2 protein | affects activity | 17173375
|
D013148 |
Spironolactone |
Spironolactone results in increased activity of NR3C2 protein | increases activity | 15780662
|
D013148 |
Spironolactone |
Spironolactone binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 15961248
|
D013148 |
Spironolactone |
Spironolactone inhibits the reaction [Phenylephrine results in increased localization of NR3C2 protein] | decreases reaction|increases localization | 19966502
|
D014284 |
Triiodothyronine |
Triiodothyronine affects the expression of NR3C2 mRNA | affects expression | 17403546
|
D013974 |
Thyroxine |
Thyroxine affects the expression of NR3C2 mRNA | affects expression | 17403546
|
D013739 |
Testosterone |
Testosterone binds to NR3C2 protein | affects binding | 17105867
|
D013739 |
Testosterone |
Testosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | decreases reaction|increases activity | 17105867
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of NR3C2 mRNA | increases expression | 16533503
|
C047426 |
venlafaxine |
venlafaxine results in decreased expression of NR3C2 mRNA | decreases expression | 11406320
|
C025643 |
vinclozolin |
vinclozolin binds to and results in decreased activity of NR3C2 protein | affects binding|decreases activity | 16750840
|
D014867 |
Water |
NR3C2 protein affects the abundance of Water | affects abundance | 15802372
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
7.67 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.67 | 18926900 17676605 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.04 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.04 | 11192467 |
MESH:D055371 |
Acute Lung Injury |
|
Bleomycin |
8.48 | 17118201 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
8.48 | 20601635 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.87 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.40 | 6695378 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.26 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.46 | 17306315 16712894 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.88 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.34 | 15513908 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.40 | 15513904 |
MESH:D000860 |
Anoxia |
|
Bleomycin |
4.98 | 15782499 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.41 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
13.07 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
13.07 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
13.07 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.65 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.74 | 17460149 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
3.27 | 17659584 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.45 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.50 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
3.41 | 19232924 18775368 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
3.91 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
3.88 | 19483382 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.11 | 15306635 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.90 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.84 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.06 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.06 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
2.06 | 17261762 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.34 | 16777450 17626835 14754758 15516495 19059883 18315731 18417511 |
MESH:D002056 |
Burns |
|
Ethanol |
4.23 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.31 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.36 | 16227642 3786805 18705752 10355542 15700767 16097048 15673190 16124888 15721981 16050911 16192424 16011737 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
10.29 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
10.29 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
10.29 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
10.29 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
10.29 | 15763234 18788625 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
10.29 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
9.69 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Bleomycin |
9.69 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
9.69 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
9.69 | 18922899 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
10.28 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
10.28 | 15728586 17124262 16170337 11179087 11754973 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
10.28 | 18093424 |
MESH:D002318 |
Cardiovascular Diseases |
|
Aldosterone |
7.51 | 11230374 |
MESH:D002318 |
Cardiovascular Diseases |
|
Spironolactone |
7.51 | 11230374 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
9.43 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
9.43 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.43 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.51 | 20678186 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.60 | 19486331 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.35 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
6.06 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Hydrocortisone |
6.06 | 15826874 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.42 | 15824018 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
5.12 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
5.12 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
5.12 | 10194807 15513904 11873399 19302082 15451040 11198716 15451039 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Hydrocortisone |
5.12 | 17728286 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
3.93 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.49 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.49 | 18551238 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
7.78 | 15014590 |
MESH:D003866 |
Depressive Disorder |
|
venlafaxine |
7.78 | 20305041 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.01 | 12438553 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.07 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
7.27 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Hydrocortisone |
7.27 | 7237001 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.02 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.14 | 20216337 16538175 16538176 15057820 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
10.48 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
10.48 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
10.48 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
10.48 | 7179309 15968718 4309450 19336974 9327722 3732212 21278145 16177239 7440962 11566570 17522070 19085960 6884620 3786805 16227642 10092053 2869522 15998439 10915739 6623471 7120509 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
10.48 | 11566570 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
4.14 | 20216337 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.19 | 20016425 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.05 | 12438553 |
MESH:D004487 |
Edema |
|
Bleomycin |
13.52 | 17118201 |
MESH:D004487 |
Edema |
|
Dexamethasone |
13.52 | 19703484 |
MESH:D004487 |
Edema |
|
Fluoxetine |
13.52 | 12798668 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
13.52 | 8273558 16716910 8113982 11698051 9599246 15177302 7812673 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
8.25 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.25 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.39 | 16134523 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
4.85 | 20485159 19915237 18855540 16538176 16415921 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
4.79 | 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
4.54 | 16628512 15008574 17116037 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
3.76 | 20417680 19620853 18234410 19700373 17178248 821787 7988514 19439326 17465707 9014606 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
4.93 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
4.69 | 15276670 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.29 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.18 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.18 | 16704527 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.04 | 20485159 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
10.96 | 12795759 16045604 12631006 15959796 16239168 61145 19224547 17595544 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
10.96 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
10.96 | 18620774 19236843 16409862 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.22 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.87 | 15513904 10194807 15451040 16946407 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
7.28 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.28 | 12639820 12168785 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.41 | 7506515 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.57 | 20016425 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.26 | 15046732 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.50 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.86 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.25 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.79 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
3.77 | 17162496 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
Spironolactone |
5.60 | 16928621 |
MESH:D006042 |
Goiter |
|
perchlorate |
4.91 | 18801409 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.42 | 20471113 |
MESH:D006333 |
Heart Failure |
marker/mechanism |
|
| 15722665 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.99 | 15720958 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.19 | 19110552 19900420 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.91 | 7520565 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.21 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
Bleomycin |
6.65 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.65 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
9.74 | 14716179 |
MESH:D019584 |
Hot Flashes |
|
venlafaxine |
9.74 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.38 | 18783367 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.87 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.10 | 16899240 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.36 | 10459572 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
4.79 | 18773962 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.70 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
7.70 | 17042910 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
7.70 | 12717712 8949925 |
OMIM:605115 |
HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY |
marker/mechanism |
|
| |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.67 | 15338365 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.21 | 14678291 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.17 | 12791704 18502941 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.28 | 12002444 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Spironolactone |
5.73 | 19822448 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.76 | 17426086 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
10.55 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
10.55 | 18031379 8137927 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.41 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.98 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.88 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
5.88 | 16467254 |
MESH:D007249 |
Inflammation |
|
Bleomycin |
16.92 | 17118201 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
16.92 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
16.92 | 17296493 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
16.92 | 12798668 |
MESH:D007249 |
Inflammation |
|
Progesterone |
16.92 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
16.92 | 8273558 15177302 7812673 7562506 11698051 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
4.02 | 15513904 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.00 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.17 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.17 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
10.35 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
10.35 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
10.35 | 12371664 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.79 | 15451040 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.30 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.50 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
4.34 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.99 | 17174718 16943688 16239168 11408273 17157831 11903743 16221502 21278145 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
5.99 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.66 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.32 | 12632514 18263696 18205269 16192424 15925388 18156304 17761835 17565644 16638106 15123356 15818738 16015684 17708605 12586293 18279442 16027843 18006644 17976157 14620537 18705752 17922224 17900296 13678700 18429990 12667390 12609069 18395914 18317297 16248980 14724832 18210741 16033810 14716496 15052691 12546737 17631135 17869086 12741479 12666154 16116963 17823541 11481614 14512876 18395095 15370692 18187930 18412020 15650968 18376398 15362042 17557913 12632512 15673190 15959796 18251166 16097048 15931870 15893842 17481882 18418968 12445418 17640975 18472094 12445421 17714472 15996030 12898905 16011737 17721639 18420326 17805973 20821823 18054572 15876570 17525996 17944888 15338365 18166357 16136751 15057751 12389079 17766677 15730626 14716833 12649538 18481824 17698563 18339082 10355542 14748882 18277467 12958196 18472332 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
3.32 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.32 | 18166357 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
1.97 | 17285989 16246199 15720792 15830285 16964402 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.23 | 17207112 17347304 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.74 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.96 | 14706259 16899240 |
MESH:D017114 |
Liver Failure, Acute |
|
venlafaxine |
8.96 | 19857765 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
12.33 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
12.33 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
12.33 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
12.33 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.33 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
8.27 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
8.27 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
8.27 | 12014681 15583823 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.54 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.54 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.43 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
9.70 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
9.70 | 20064080 18816296 20135361 17053015 6695378 20464547 20869020 18569708 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Bleomycin |
9.70 | 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
9.70 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
9.70 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
9.70 | 15276417 16712894 17306315 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.70 | 11807781 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.44 | 16628512 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
8.58 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
8.58 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
8.58 | 8985016 |
MESH:D008545 |
Melanoma |
|
Bleomycin |
3.54 | 15577320 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.54 | 16487513 19082730 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.78 | 18411066 15451040 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
7.51 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
venlafaxine |
7.51 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.57 | 9014606 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.35 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.67 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
venlafaxine |
4.46 | 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.86 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.20 | 15744524 15867202 16118317 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.29 | 9809623 |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.45 | 8041377 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.04 | 20399394 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.91 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.91 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.29 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.29 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.25 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.00 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.92 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
4.50 | 16990009 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.86 | 12854658 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
10.38 | 20418887 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
venlafaxine |
10.38 | 17503984 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.65 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.65 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
5.04 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.45 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.45 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Carbamazepine |
6.58 | 15215642 |
MESH:D010146 |
Pain |
|
Fluoxetine |
6.58 | 12798668 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
5.13 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.13 | 15976015 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.88 | 12065085 8330346 18404319 18922899 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.28 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.49 | 17145499 17679678 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.71 | 16369182 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
5.58 | 8041377 |
MESH:D011014 |
Pneumonia |
|
Bleomycin |
9.98 | 16317386 18024389 17071938 |
MESH:D011014 |
Pneumonia |
|
Ozone |
9.98 | 18007984 18929643 18381685 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.86 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.30 | 21297632 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
4.73 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
8.68 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
8.68 | 18042343 19015723 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.50 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
4.67 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.37 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.37 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.50 | 18629315 |
MESH:D011546 |
Pseudohypoaldosteronism |
marker/mechanism |
|
| |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
5.16 | 9591791 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.07 | 16882103 |
MESH:D011654 |
Pulmonary Edema |
|
Bleomycin |
4.88 | 15808516 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Bleomycin |
3.69 | 16314464 15322207 17241526 18162602 12624602 17434272 12574379 17177178 16115399 21435439 11554783 15541506 14609568 18008008 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.77 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.62 | 18379247 11700416 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.69 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
11.71 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
11.71 | 18551238 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
11.71 | 9046859 19414003 9844417 16180713 16938433 15946322 16876388 |
MESH:D012640 |
Seizures |
|
Ethanol |
11.71 | 9754883 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.46 | 8704074 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.76 | 16631401 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.27 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.31 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.31 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.31 | 8330346 8985016 18404319 12065085 11807781 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
4.69 | 19414003 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.85 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.46 | 12854658 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
4.79 | 16415921 19694795 19915237 15057820 18855540 16538176 20485159 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.89 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.41 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.41 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.29 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.29 | 9211565 16755016 17189318 11906479 9562338 17918041 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.88 | 9754883 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
5.20 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
3.36 | 15710170 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
10.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
10.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
10.39 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
10.39 | 17306315 11723127 16712894 16452187 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.55 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.55 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.39 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.30 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
10.30 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.99 | 17056641 |
MESH:D015431 |
Weight Loss |
|
Bleomycin |
5.21 | 12624602 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.00 | 17120751 |